In an interview during The American Journal of Managed Care®'s Institute for Value-Based Medicine® event, held with Sutter Health, Ryan Stice, PharmD, BCPS, explains the impact virtual population health teams can have on improving access to care for patients with cardiometabolic conditions.
At The American Journal of Managed Care® Institute for Value-Based Medicine® event, hosted in partnership with Sutter Health in San Francisco, California, Ryan Stice, PharmD, BCPS, chief pharmacy officer for Sutter Health, shared his strategy for extending services to the full community in the presentation, "Expanding Access to Care Using Virtual Population Health Teams."
In this interview, he explains the approach's impact on improving access to care for patients with cardiometabolic conditions. These teams provide ongoing support and coaching between physician visits, ensuring medication adherence and addressing financial barriers to treatment.
Transcript
Can you provide an overview of the concept of virtual population health teams and how they contribute to expanding access to care?
So typically, a patient sees their cardiologist or care provider once or twice a year, but their care really requires a lot of extensive follow-up in between those visits. And so, the virtual services really partner the virtual team with the patient through a collaborative practice agreement with the physician. And from there, we're able to see the patient weekly, every other week, whenever it's really needed. We become a health coach in a way, with a pharmacy experience and background, to help bring them from zero medications for heart failure to 4 medications for heart failure. We find that just leaving a physician's office with that prescription is not enough—that they need that coach, that frequent follow-up, that partner in their journey to achieve the right level of care that they need.
How does this approach address the high burden of cardiometabolic conditions in the US?
So, we're essentially opening up more access points for patients to our health care system. They can see a provider in the office in a traditional setting but then have access in between those appointments to this care team that’s on top of how they're progressing. It can also help them with cost-related issues for medications. Many of these medications are incredibly expensive. So many patients today have very-high-deductible health plans and so we're able to help them navigate to financial assistance resources that help them cover those costs.
And also just address their questions. Only about 30% of new prescriptions are actually filled by the patient and continued. And so we're all about taking that prescribed treatment after the physician has diagnosed the patient, making sure the patient actually continues on the therapy and that we see the true population health benefit and change in their outcomes that we’re intended to provide.
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
2 Commerce Drive
Cranbury, NJ 08512